APA (7th ed.) Citation

RW, H., SM, T., SW, G., S, G., SR, J., S, A., & WP, M. (2025). A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. Current oncology (Toronto, Ont.), 32(10), . https://doi.org/10.3390/curroncol32100532

Chicago Style (17th ed.) Citation

RW, Holloway, Temkin SM, Gordon SW, Gupta S, Jada SR, Ahmad S, and McGuire WP. "A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer." Current Oncology (Toronto, Ont.) 32, no. 10 (2025). https://doi.org/10.3390/curroncol32100532.

MLA (9th ed.) Citation

RW, Holloway, et al. "A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer." Current Oncology (Toronto, Ont.), vol. 32, no. 10, 2025, https://doi.org/10.3390/curroncol32100532.